Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-241643
Filing Date
2025-10-16
Accepted
2025-10-16 18:12:32
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5396
  Complete submission text file 0001193125-25-241643.txt   6895
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Issuer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AARDVARK THERAPEUTICS, INC. 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050 SAN DIEGO CA 92122
Business Address
Jones Bryan (Reporting) CIK: 0002045615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42513 | Film No.: 251398570